# TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients

> **NCT01409733** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Heidelberg University** · enrollment: 20 (estimated)

## Conditions studied

- Stage IV Melanoma Patients With Unresectable Liver Metastases

## Interventions

- **DEVICE:** TACE using Drug Eluting Beads loaded with Doxorubicin

## Key facts

- **NCT ID:** NCT01409733
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2012-09
- **Final completion:** 2012-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-08-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01409733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01409733, "TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01409733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*